Atrial fibrillation trials in Latvia
5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Where
- Daugavpils, Liepaja, Ogre, Riga, Valmiera
- Age
- 18 years and over
- People
- 15,364 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07626411 · EU 2025-521617-97-00 - Phase 3Taking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- Where
- Daugavpils, Liepaja, Riga
- Age
- 18 years and over
- People
- 2,628 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07430956 · EU 2025-521618-25-00 - Phase 3Taking peopleStudy to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Where
- Daugavpils, Riga, Siguldas Pagasts, Valmiera
- Age
- 65 years and over
- People
- 2,500 worldwide
- Run by
- Anthos Therapeutics, Inc.
See details and how to joinNCT05712200 · EU 2023-503224-66-00 - No phaseTaking peopleObservation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
- Where
- Riga
- Age
- 18 years and over
- People
- 1,400 worldwide
- Run by
- Biotronik SE & Co. KG
See details and how to joinNCT04075084 - Phase 4Not yet taking people in LatviaAn open-label, randomized clinical trial comparing Etacizin versus Propafenone in Atrial Fibrillation
- Where
- Riga
- Age
- 18 years and over
- People
- 30
- Run by
- Olpha AS
See details and how to join2025-521267-13-01 · EU 2025-521267-13-01